# The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

> **NCT07459283** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **FindCure Biosciences (ZhongShan) Co., Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Maligant Solid Tumor
- Head & Neck Cancer
- Thyroid Cancer
- Lung Cancer - Non Small Cell Squamous
- Breast Cancer
- Sarcoma

## Interventions

- **DRUG:** INN805

## Key facts

- **NCT ID:** NCT07459283
- **Lead sponsor:** FindCure Biosciences (ZhongShan) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-12
- **Final completion:** 2027-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07459283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07459283, "The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07459283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*